Closed tender

Provision of Extended Half-Life Recombinant Factor IX for St James’s Hospital

Details

Value
€22,000,000
Topic
Blood products
Published
9 January 2025
Submission
13 February 2025

Tender description

The CA is tendering for the Provision of Extended Half-Life Recombinant Factor IX for St James’s Hospital, the Health Service Executive (HSE) and the Health Care Executive funded agencies collectively known as the Contracting Authority (CA) 2025

Timeline

  1. TenderThis notice (current page)
    Published
    9 Jan 2025
    Deadline
    13 Feb 2025

About the buyer

St James's Hospital is Ireland's largest acute academic teaching hospital and a registered charity, and buys as a healthcare organisation through its own procurement unit. The Procurement Unit sits within the Finance Directorate. Directorates draw on that unit for procurement expertise and market engagement. The hospital has tendered patient equipment maintenance by competitive dialogue, split into three lots.

Over the past 5 years, most of St James's Hospital's contract awards have been in medical equipment and pharmaceuticals, laboratory and precision equipment and security and defence equipment.

AI insights

  • Who did St James's Hospital use last time?
  • Will St James's Hospital buy this again?
  • What was St James's Hospital trying to fix?

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

14 similar open tenders

See more open tenders related to Blood products.

Explore all open tenders

Related buyers

Buyers similar to St James's Hospital.

View all buyers

Finding public sector work shouldn't be hard

Make your next tender search effortless with Stotles. Set up alerts, find decision maker contacts and never miss a good-fit opportunity again.